To Vape or Not to Vape

Vaping Clinical Trial

Official title:

To Vape or Not to Vape

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT05240027
• Other study ID #: 009.ONC.2020.D
• Status: Terminated
• Phase: N/A
• Start date: March 13, 2020
• Est. completion date: February 26, 2021

Study information

• Verified date: May 2022
• Source: Methodist Health System
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The overall goal of this study is to increase knowledge of vaping and its associated risks. This study will find the patterns of vaping, and how it all started among adolescents. Investigators want to know if students are aware of the serious and long term effects of vaping. This program titled, "To Vape or Not to Vape", will provide education to adolescents and young adults about the potential risk of vaping in an effort to assist with lowering the usage rates within the population. Content will include information about current statistics, potential short-term and long-term side-effects, and healthy alternatives for dealing with stress and peer-pressure. Investigators anticipate that this program will increase this population's knowledge about the risks of vaping products, and deter them from future use of the products. Effectiveness of this program will be measured by pre and post-tests. Investigators believe this program will make at least 50 percent of the participants more aware of the dangers and consequences of vaping, potentially lowering the rates of those participating in this habit while also preventing others from starting.

Description:

The overall goal of this study is to increase knowledge of vaping and its associated risks. This study will find the patterns of vaping, and how it all started among adolescents. Investigators want to know if students are aware of the serious and long term effects of vaping. This program titled, "To Vape or Not to Vape", will provide education to adolescents and young adults about the potential risk of vaping in an effort to assist with lowering the usage rates within the population. Content will include information about current statistics, potential short-term and long-term side-effects, and healthy alternatives for dealing with stress and peer-pressure. Investigators anticipate that this program will increase this population's knowledge about the risks of vaping products, and deter them from future use of the products. Effectiveness of this program will be measured by pre and post-tests.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 363
• Est. completion date: February 26, 2021
• Est. primary completion date: February 26, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 12 Years and older

Eligibility

Inclusion Criteria:

• The program's targeted population is starting at the middle school grade levels, up to college.
• Live in the DFW metroplex
• Willing to participate throughout the presentation

Exclusion Criteria:

• Less than 12 years old
• Students that are not in the DFW metroplex

Related Conditions & MeSH terms

• Vaping

Intervention

Behavioral:
• Vape use survey
pre & post test surveys

Locations

Country	Name	City	State
United States	Methodist Dallas Medical Center	Dallas	Texas

Sponsors (1)

Lead Sponsor	Collaborator
Methodist Health System

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	percentage of vape users	Investigators will obtain the percentage of vape users and their reasons for vaping from information gathered from (per-test questionnaire).	The program will last 5 months between March 2020 and August 2020.
Primary	reasons for vaping	Investigators will obtain the percentage of vape users and their reasons for vaping from information gathered from (per-test questionnaire).	The program will last 5 months between March 2020 and August 2020.
Secondary	Educational Effectiveness	Changes in the degree of understanding will be assessed from the results of the pre and post-test (questionnaire).	The program will last 5 months between March 2020 and August 2020.